Recombinant B7-H4 (Alsevalimab Biosimilar) 抗体
Quick Overview for Recombinant B7-H4 (Alsevalimab Biosimilar) 抗体 (ABIN7581257)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
Expression System
- CHO Cells
-
原理
- Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab)
-
产品特性
- Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 104.42 kDa.
-
纯度
- >95 %
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Conditions: Breast Cancer Ovarian Cancer
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- B7-H4 (Alsevalimab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Synonyms: O8E, OV064, B7H4, B7S1, VTCN1, V-set domain-containing T-cell activation inhibitor 1
-
分子量
- 104.42 kDa
-
UniProt
- Q7Z7D3
抗原
-